| 臺大學術典藏 |
2021-01-05T03:34:26Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Wang Y.-T.; Lin C.-W.; Tang J.-L.; MING YAO; Yeh K.-H.; Ma W.-L.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-04T12:13:12Z |
Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy
|
Yeh K.H.; Cheng A.L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Liu M.-Y.; Cheng A.-L.; Hsu C.-H.; Wang C.-H.; Tang J.-L.; Yeh K.-H.; Kao W.-Y.; Huang M.-C.; Chang M.-C.; HWEI-FANG TIEN; Chao T.-Y.; Lin Z.-Z.; Su I.-J.; Huang C.-L. |
| 國立成功大學 |
2021 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
|
Yoshino, T.;Argil�s, G.;Oki, E.;Martinelli, E.;Taniguchi, H.;Arnold, D.;Mishima, S.;Li, Y.;Smruti, B.K.;Ahn, J.B.;Faud, I.;Chee, Chee C.E.;Yeh, K.-H.;Lin, P.-C.;Chua, Chua C.;Hasbullah, Hasbullah H.H.;Lee, M.A.;Sharma, A.;Sun, Y.;Curigliano, G.;Bando, H.;Lordick, F.;Yamanaka, T.;Tabernero, J.;Baba, E.;Cervantes, A.;Ohtsu, A.;Peters, S.;Ishioka, C.;Pentheroudakis, G. |
| 國立成功大學 |
2021 |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Yeh, K.-H.;Yang, T.-S.;Hsu, T.-C.;Tzu-Liang, Chen W.;Chen, H.-H.;Teng, H.-W.;Lin, B.-W.;Kuan, F.-C.;Chiang, F.-F.;Duann, C.-W.;Li, Y.-S.;Lin, M.-T.;Fiala-Buskies, S.;Ducreux, M.;Wang, J.-Y. |
| 國立成功大學 |
2021 |
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
|
Boku, N.;Satoh, T.;Ryu, M.-H.;Chao, Y.;Kato, Kato K.;Chung, H.C.;Chen, J.-S.;Muro, K.;Kang, W.K.;Yeh, K.-H.;Yoshikawa, T.;Oh, S.C.;Bai, L.-Y.;Tamura, Tamura T.;Lee, K.-W.;Hamamoto, Y.;Kim, J.G.;Chin, K.;Oh, D.-Y.;Minashi, K.;Cho, J.Y.;Tsuda, M.;Nishiyama, T.;Chen, L.-T.;Kang, Y.-K. |
| 臺大學術典藏 |
2020-12-29T03:08:57Z |
Disseminated Mycobacterium kansasii infection in an HIV-negative patient presenting with mimicking multiple bone metastases
|
Tsai C.-W.;Jann-Tay Wang;Tsai C.-C.;Yeh K.-H.; Tsai C.-W.; JANN-TAY WANG; Tsai C.-C.; Yeh K.-H. |
| 臺大學術典藏 |
2020-12-02T02:36:35Z |
Panhypopituitarism caused by solitary parasellar metastasis from lung cancer
|
Ko J.-C.; Pan-Chyr Yang; Huang T.-S.; Yeh K.-H.; Kuo S.-H.; Luh K.T.; Ko J.-C.; PAN-CHYR YANG; Huang T.-S.; Yeh K.-H.; Kuo S.-H.; Luh K.T. |
| 臺大學術典藏 |
2020-12-02T02:36:18Z |
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
|
Yang C.-H.;Cheng A.-L.;Yeh K.-H.;Yu C.-J.;Lin J.-F.;Pan-Chyr Yang; Yang C.-H.; Cheng A.-L.; Yeh K.-H.; Yu C.-J.; Lin J.-F.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:35:41Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
PAN-CHYR YANG; Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Yeh K.-H.;Yu Y.-C.;Whang-Peng J.;Pan-Chyr Yang; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J. |
| 臺大學術典藏 |
2020-12-02T02:34:25Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Pan-Chyr Yang; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-11-19T03:43:39Z |
Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: A pilot study
|
Yeh K.-H.; Cheng A.-L.; Chen Y.-C.; Chen B.-R.; Lee W.-J.; Lin J.-T.; PO-HUANG LEE; Chang K.-J.; Wang C.-H.; Wang T.-H. |
| 臺大學術典藏 |
2020-11-19T03:43:22Z |
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
|
Yeh K.-H.;Cheng A.-L.;Lin M.-T.;Hong R.-L.;Hsu C.-H.;Lin J.-F.;Chang K.-J.;Po-Huang Lee;Chen Y.-C.; Yeh K.-H.; Cheng A.-L.; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; Chang K.-J.; PO-HUANG LEE; Chen Y.-C. |
| 臺大學術典藏 |
2020-11-19T03:43:21Z |
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers
|
Yeh K.-H.; Chen C.-L.; Shun C.-T.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE; Chen Y.-C.; Cheng A.-L. |
| 臺大學術典藏 |
2020-11-19T03:43:19Z |
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE; Chen Y.-C.; Cheng A.-L. |
| 臺大學術典藏 |
2020-11-19T03:43:16Z |
Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE; Chen Y.-C.; Cheng A.-L.; Yeh K.-H.;Shun C.-T.;Chen C.-L.;Lin J.-T.;Lee W.-J.;Po-Huang Lee;Chen Y.-C.;Cheng A.-L. |
| 臺大學術典藏 |
2020-11-13T07:56:51Z |
A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need
|
Huang W.-T.; Lee M.-Y.; Ko W.-H.; Ko W.-H.; Lu C.-H.; Lu C.-H.; Chiou T.-J.; SHIOW-CHING SHUN; Rau K.-M.; Rau K.-M.; Rau K.-M.;Rau K.-M.;Shiow-Ching Shun;Chiou T.-J.;Lu C.-H.;Lu C.-H.;Ko W.-H.;Ko W.-H.;Lee M.-Y.;Huang W.-T.;Yeh K.-H.;Chang C.-S.;Chang C.-S.;Hsieh R.-K.; Yeh K.-H.; Chang C.-S.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-11-13T07:56:51Z |
A Pilot Study of Metabolomic Pathways Associated With Fatigue in Survivors of Colorectal Cancer
|
SHIOW-CHING SHUN; Liang J.-T.; Miaskowski C.; Kuo T.-C.; Tseng Y.J.; Yeh K.-H.; Kuo C.-H.; Kober K.M.; Chou Y.-J.; Chou Y.-J.;Kober K.M.;Kuo C.-H.;Yeh K.-H.;Kuo T.-C.;Tseng Y.J.;Miaskowski C.;Liang J.-T.;Shiow-Ching Shun |
| 臺大學術典藏 |
2020-11-02T02:05:23Z |
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas
|
Cheng A.-L.; Doong S.-L.; Lin J.-T.; Mao T.-L.; Chen C.-L.; Kuo S.-H.; Chen L.-T.; Yeh K.-H.; MING-SHIANG WU; Hsu H.-C.; Yeh P.-Y. |
| 臺大學術典藏 |
2020-11-02T02:05:20Z |
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 )
|
Cheng A.-L.; Lin J.-T.; Chen C.-L.; Tzeng Y.-S.; Hsu H.-C.; MING-SHIANG WU; Doong S.-L.; Mao T.-L.; Chen L.-T.; Yeh K.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2020-11-02T02:05:04Z |
Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma
|
Cheng A.-L.; Lin J.-T.; Hsu P.-N.; Chen J.-Y.; Tzeng Y.-S.; Kuo S.-H.; Yeh P.-Y.; Chen L.-T.; MING-SHIANG WU; Lin C.-W.; Yeh K.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:50Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Chen L.-T.; Tzeng Y.-S.; Yeh K.-H.; MING-SHIANG WU; Hsu C.-H.; Lin C.-W.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:49Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Wang H.-P.; Chen L.-T.; Cheng A.-L.; Hsu P.-N.; MING-SHIANG WU; Lin C.-W.; Yeh K.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:44Z |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; MING-SHIANG WU; Hsu P.-N.; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; Wang H.-P.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-11-02T02:04:37Z |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; MING-SHIANG WU; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; Cheng A.-L. |
| 臺大學術典藏 |
2020-11-02T02:04:36Z |
Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; MING-SHIANG WU; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-11-02T02:04:23Z |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
|
Cheng A.-L.; Chen L.-T.; Hsu P.-N.; MING-SHIANG WU; Shun C.-T.; Wei M.-F.; Lee H.-W.; Yeh K.-H.; Lin C.-W.; Kuo S.-H.; Tsai H.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:23Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
MING-SHIANG WU; Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Cheng A.-L.; Chen L.-T.; Wang H.-P.; Liou J.-M.; Wei M.-F.; Lin C.-W.; MING-SHIANG WU; Yeh K.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2020-09-29T06:53:04Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Kuo S.-H.; Cheng A.-L.; Tien Y.-W.; Yeh K.-H.; Hsu C.-H.; Hsu C.; Wu H.; Guo J.-C.; TING-CHUN KUO; Yang S.-H. |
| 臺大學術典藏 |
2020-09-29T06:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; TING-CHUN KUO; Tien Y.-W.; Kuo S.-H.; Guo J.-C.; Lee J.-C.; Yang S.-H. |
| 臺大學術典藏 |
2020-09-29T01:47:44Z |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
Yeh K.-H.; Cheng A.-L.; Yang J.C.-H.; Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN; Hu F.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:59Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
JIN-YUAN SHIH; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.; Chen K.-Y.; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C. |
| 臺大學術典藏 |
2020-06-16T07:53:31Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Liang-In Lin;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-06-16T07:53:29Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Liang-In Lin;Yeh K.-H.;Jeng Y.-M.; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; LIANG-IN LIN; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-06-16T07:53:23Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Chen K.-H.;Liang-In Lin;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; LIANG-IN LIN; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-06-03T08:10:43Z |
Panhypopituitarism caused by solitary parasellar metastasis from lung cancer
|
Ko J.-C.; Yang P.-C.; TIEN-SHANG HUANG; Yeh K.-H.; Kuo S.-H.; Luh K.T.; Ko J.-C.;Yang P.-C.;Tien-Shang Huang;Yeh K.-H.;Kuo S.-H.;Luh K.T. |
| 臺大學術典藏 |
2020-05-26T09:27:35Z |
Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome
|
Yeh K.H;Hsieh H.C;Tang J.L;Lin M.T;Chih-Hsin Yang;Chen Y.C.; Yeh K.H; Hsieh H.C; Tang J.L; Lin M.T; CHIH-HSIN YANG; Chen Y.C. |
| 臺大學術典藏 |
2020-05-26T09:27:35Z |
Long?�term disease?�free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third?�complementarity?�determining region?�specific probes
|
Yeh K.??H;Lin M.??T;Tang J.??L;Chih-Hsin Yang;Tsay W;Chen Y.??C.; Yeh K.?�H; Lin M.?�T; Tang J.?�L; CHIH-HSIN YANG; Tsay W; Chen Y.?�C. |
| 臺大學術典藏 |
2020-05-26T09:27:34Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Hsu C;Yeh K.-H;Hong R.-L;Chih-Hsin Yang;Lin M.-T;Chen Y.-C;Cheng A.-L.; Hsu C; Yeh K.-H; Hong R.-L; CHIH-HSIN YANG; Lin M.-T; Chen Y.-C; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:33Z |
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
|
Chih-Hsin Yang;Cheng A.-L;Yeh K.-H;Yu C.-J;Lin J.-F;Yang P.-C.; CHIH-HSIN YANG; Cheng A.-L; Yeh K.-H; Yu C.-J; Lin J.-F; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:31Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H;Cheng A.-L;Hsu C;Chih-Hsin Yang;Lu Y.-S;Lin C.-C;Bu C.-F;Yeh K.-H.; Hsu C.-H; Cheng A.-L; Hsu C; CHIH-HSIN YANG; Lu Y.-S; Lin C.-C; Bu C.-F; Yeh K.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C;Shen Y.-C;Chih-Hsin Yang;Yeh K.-H;Lu Y.-S;Hsu C.-H;Liu H.-T;Li C.-C;Chen J.-S;Wu C.-Y;Cheng A.-L.; Hsu C; Shen Y.-C; CHIH-HSIN YANG; Yeh K.-H; Lu Y.-S; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Lu Y.-S;Hsu C;Li C.-C;Kuo S.-H;Yeh K.-H;Chih-Hsin Yang;Hsu C.-H;Wu C.-Y;Cheng A.-L.; Lu Y.-S; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; CHIH-HSIN YANG; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Lu Y.S;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Chih-Hsin Yang;Cheng A.L.; Yeh K.H; Lu Y.S; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; CHIH-HSIN YANG; Cheng A.L. |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Chih-Hsin Yang;Chen M.-C;Cheng A.-L;Hsu C.-H;Yeh K.-H;Yu Y.-C;Whang-Peng J;Yang P.-C.; CHIH-HSIN YANG; Chen M.-C; Cheng A.-L; Hsu C.-H; Yeh K.-H; Yu Y.-C; Whang-Peng J; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:26Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Hsu C.-H; Cheng J.C; Wang H.-P; Lee J.-M; Yeh K.-H; CHIH-HSIN YANG; Lin J.-T; Cheng A.-L; Lee Y.-C.; Lin C.-C;Hsu C.-H;Cheng J.C;Wang H.-P;Lee J.-M;Yeh K.-H;Chih-Hsin Yang;Lin J.-T;Cheng A.-L;Lee Y.-C.; Lin C.-C |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C;Yeh K.-H;Chih-Hsin Yang;Hsu C;Tsai Y.-C;Hsu W.-L;Cheng A.-L;Hsu C.-H.; Lin C.-C; Yeh K.-H; CHIH-HSIN YANG; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C;Cheng A.-L;Hsu C.-H;Lu Y.-S;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Chih-Hsin Yang; Lin C.-C; Cheng A.-L; Hsu C.-H; Lu Y.-S; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:19Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C. |
